Forecast & RatingOnly 1 analyst currently covers Lakewood-Amedex Biotherapeutics (LABT.US), with a price target of $12.00. The sample is very small, so treat this as a reference only. Data as of Aug 26, 2026; this does not constitute investment advice.
Aug 26, 2026Price forecast
$12.00788.23%
Forecast & Rating-
0analysts
Target price forecast
Forecast dateSep 28, 2026
Forecast met0.0%
Stock price$1.35
Avg. target$12.0
High target$12
Low target$12
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.